Clinical Trials

29 enrolled

Liver Neoplasms

NCT07287098 2026-04-17

preEMBER

600 enrolled

Breast Neoplasms

NCT07328503 2026-04-17

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

LymphoidOther hematologic neoplasm

20 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07387198 2026-04-17

NeoMatryx

135 enrolled

Dermatologic

Skin Neoplasms, Carcinoma, Merkel Cell

NCT07453095 2026-04-17

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

41 enrolled

Lymphoid

Recurrence, Lymphoma, Mantle-Cell

NCT07524530 2026-04-17

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

LymphoidOther hematologic neoplasm

98 enrolled

Leukemia, Lymphoma, Hematologic Neoplasms

NCT07527806 2026-04-17

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

156 enrolled

Breast Neoplasms

NCT07535632 2026-04-17

BEST

58 enrolled

Colorectal Neoplasms

NCT07535762 2026-04-17

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

36 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

NCT07535905 2026-04-17

REVIVE

96 enrolled

Genitourinary

Hypogonadism, Prostatic Neoplasms

NCT07537400 2026-04-17

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

10 enrolled

Neuroblastoma

NCT07537777 2026-04-17

Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy

29 enrolled

Carcinoma, Hepatocellular

NCT07537972 2026-04-17

Denosumab Strategy for Liver Cancer With Bone Metastases

50 enrolled

Carcinoma, Hepatocellular

NCT07349771 2026-04-16

Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

72 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07361133 2026-04-16

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

120 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT07470489 2026-04-16

Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer

12 enrolled

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT07533227 2026-04-16

FMT-CACH

66 enrolled

Cachexia, Neoplasms

NCT07533942 2026-04-16

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

30 enrolled

Meningioma

NCT07172256 2026-04-15

CUE-101with Pembrolizumab for LA-HPV+HNSCCs

30 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07192237 2026-04-15

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

LymphoidOther hematologic neoplasm

40 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07524894 2026-04-15

SNIFF

126 enrolled

Head and Neck Neoplasms

NCT07530224 2026-04-15

JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis

35 enrolled

Immune Checkpoint Inhibitor-Induced Dermatitis

NCT07530549 2026-04-15

A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy

40 enrolled

Esophageal Neoplasms

NCT07450599 2026-04-14

CHINANEO

250 enrolled

Genitourinary

High-Risk Localized Prostate Cancer

NCT07527169 2026-04-14

A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma

16 enrolled

Esthesioneuroblastoma, Olfactory

NCT07527325 2026-04-14

Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

35 enrolled

Dermatologic

Melanoma

NCT07527520 2026-04-14

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

165 enrolled

Rectal Neoplasms

NCT07527858 2026-04-14

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

170 enrolled

Advanced Microsatellite Stable Colorectal Cancer

NCT07528417 2026-04-14

MYELO-CAN:ABX

MyeloidOther hematologic neoplasm

75 enrolled

Myelodysplastic Syndromes, Myeloproliferative Disorders, Neutropenia, Leukemia, Myeloid, Acute

NCT07528768 2026-04-14

Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

750 enrolled

Triple Negative Breast Neoplasms

NCT07528898 2026-04-14

Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.

100 enrolled

Breast Neoplasms

NCT07529405 2026-04-14

CurbMF

386 enrolled

Lymphoid

Mycosis Fungoides

NCT07529483 2026-04-14

Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts

35 enrolled

Pancreatic Cystic Neoplasm

NCT07529873 2026-04-14

N'FORCE

131 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05554419 2026-04-13

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

Other hematologic neoplasm

184 enrolled

Leukemia, Myeloid, Acute

NCT06732388 2026-04-13

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

64 enrolled

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT06948084 2026-04-13

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

80 enrolled

Plasma cell

Multiple Myeloma

NCT06954987 2026-04-13

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Other hematologic neoplasm

244 enrolled

Leukemia, Myeloid, Acute

NCT07153497 2026-04-13

Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)

MyeloidOther hematologic neoplasm

132 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07349641 2026-04-13

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

55 enrolled

Gynecologic

Endometrial Hyperplasia

NCT07437950 2026-04-13

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Other hematologic neoplasm

126 enrolled

Leukemia, Myeloid, Acute

NCT07501169 2026-04-13

STAR-01

33 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07504588 2026-04-13

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

87 enrolled

Gynecologic

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma

NCT07505979 2026-04-13

SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases

90 enrolled

Brain Neoplasms

NCT07516366 2026-04-13

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

16 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT07521605 2026-04-13

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

44 enrolled

Rectal Cancer Patients

NCT07521657 2026-04-13

NF118

55 enrolled

Glioblastoma, Glioma, Neurofibromatosis 1

NCT07521670 2026-04-13

STRAP

68 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Carcinoma, Adenoid Cystic, Neoplasm Metastasis, Recurrence

NCT07522476 2026-04-13

A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma

30 enrolled

Cholangiocarcinoma

NCT07522697 2026-04-13

MITO END-4